Skip to main content

Published locations for FDA approves pembrolizumab as second-line for advanced ESCC

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. FDA approves pembrolizumab as second-line for advanced ESCC

User login

  • Reset your password
  • /content/fda-approves-pembrolizumab-second-line-advanced-escc
  • /oncologypractice/article/205752/gastroenterology/fda-approves-pembrolizumab-second-line-advanced
  • /hematology-oncology/article/205752/gastroenterology/fda-approves-pembrolizumab-second-line-advanced